{"version":"1.0","type":"rich","provider_name":"EbookNetworking","provider_url":"https://www.ebooknetworking.net","title":"Dainippon Sumitomo Pharma Announces Launch of \"Replagal(R) 3.5 mg\" for Anderson-Fabry Disease.: An article from: JCN Newswires","author_name":"Gale Reference Team","thumbnail_url":"https://www.ebooknetworking.net/books/noimage.jpg","thumbnail_width":330,"thumbnail_height":500,"html":"<a href=\"https://www.ebooknetworking.net/books_detail-B000NJLE62.html\">Dainippon Sumitomo Pharma Announces Launch of &quot;Replagal(R) 3.5 mg&quot; for Anderson-Fabry Disease.: An article from: JCN Newswires</a>","width":400,"height":300}